フローダイバージョン動脈瘤治療市場-世界の産業規模、動向、機会、予測、製品別（FDS、嚢内流路迂回デバイス）、エンドユーザー別（病院、専門クリニック）、地域別、競合別セグメント、2020-2030年

フローダイバージョン動脈瘤治療の世界市場規模は2024年に19億8,000万米ドルとなり、2030年までの年間平均成長率（CAGR）は7.72％と、予測期間中に大きな成長が見込まれています。

この市場は、生命を脅かす可能性のある脳動脈瘤に対処する緊急の必要性によって、神経インターベンション分野で急速に発展しています。この市場の特徴は、動脈瘤から血流を迂回させ、閉塞を助け、破裂のリスクを低減するように設計された低侵襲治療である分流装置の使用です。血流転換技術と神経画像技術の絶え間ない進歩は、治療の選択肢を広げ、患者の転帰を向上させています。脳動脈瘤の発生率の増加は、しばしば加齢やその他の危険因子と関連しており、効果的な治療ソリューションに対する需要をさらに押し上げています。従来の外科的アプローチに比べ、流路転換術は侵襲性が低いため、回復時間の短縮や入院期間の短縮につながります。

市場促進要因

市場の課題

分流装置は非常に効果的であるが高価であり、これらの特殊な装置のコストは治療費全体のかなりの部分を占める。

流路転換術の実施には専門的なトレーニングが必要であり、そのための教育や資格取得のための追加費用が発生します。

また、術前評価、長期入院、フォローアップケアの複雑さも、全体的なヘルスケアコストを増加させる。

機器や医療ツールの技術的進歩は、より良い治療結果をもたらす可能性がある一方で、初期費用が高くなる可能性もあります。

主な市場動向

デザイン、材料、送達システムの改良など、流体迂回装置の継続的な技術革新により、安全性と有効性が向上し、導入がさらに促進されています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のフローダイバージョン動脈瘤治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（FDS、嚢内血流遮断デバイス）
  • エンドユーザー別（病院、専門クリニック）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のフローダイバージョン動脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のフローダイバージョン動脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のフローダイバージョン動脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のフローダイバージョン動脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのフローダイバージョン動脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のフローダイバージョン動脈瘤治療市場：SWOT分析

第14章 競合情勢

• Acandis GmbH
• BALT Group
• Cardinal Health Inc
• Endologix LLC
• Evasc Medical Systems Corp
• Imperative Care Inc
• InspireMD Inc
• Johnson and Johnson
• Lepu Medical Technology Beijing Co. Ltd
• Medtronic Plc

第15章 戦略的提言

第16章 調査会社について・免責事項

The global Flow Diversion Aneurysm Treatment Market was valued at USD 1.98 billion in 2024 and is projected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 7.72% through 2030. This market is evolving rapidly within the neurointerventional sector, driven by the urgent need to address cerebral aneurysms, a potentially life-threatening condition. The market is characterized by the use of flow diversion devices, a minimally invasive treatment designed to reroute blood flow away from aneurysms, aiding in their occlusion and reducing the risk of rupture. Continuous advancements in flow diversion technologies and neuroimaging techniques are broadening treatment options and enhancing patient outcomes. The rising incidence of cerebral aneurysms, often linked to aging and other risk factors, is further propelling demand for effective treatment solutions. Compared to traditional surgical approaches, flow diversion procedures are less invasive, leading to shorter recovery times and reduced hospital stays.

Key Market Drivers

The Flow Diversion Aneurysm Treatment Market is experiencing notable growth, primarily driven by the increasing adoption of minimally invasive treatment options. This trend reflects a shift in the management of cerebral aneurysms, prioritizing less invasive procedures over traditional open surgeries. Several factors contributing to this shift include:

Minimally invasive procedures typically require smaller incisions or access points, resulting in reduced tissue damage, less pain, and faster recovery times compared to open surgery. This approach is highly appealing to both patients and healthcare providers.

Flow diversion treatments yield excellent patient outcomes, with lower complication rates and reduced risks of infection or bleeding, which boosts patient satisfaction and enhances the reputation of these procedures.

Advances in medical devices and imaging technologies have made minimally invasive treatments more precise and effective. Real-time imaging guidance plays a critical role in increasing the accuracy of flow diversion procedures.

Key Market Challenges

Despite the promising growth of the market, high procedural costs remain a significant challenge. These costs encompass various aspects of treatment, including the price of flow diversion devices, hospital fees, physician charges, and post-procedure care. Contributing factors to the elevated costs include:

Flow diversion devices, while highly effective, can be expensive, and the cost of these specialized devices forms a substantial part of the overall treatment expenses.

Performing flow diversion procedures requires specialized training, which incurs additional costs for education and certification.

The complexity of pre-operative assessments, extended hospital stays, and follow-up care also increases overall healthcare costs.

While technological advancements in devices and medical tools may lead to better outcomes, they can also result in higher upfront costs.

Reimbursement rates for flow diversion procedures in some healthcare systems may not fully cover the costs, creating financial constraints for hospitals and healthcare providers. High procedural costs can also limit patient access to these advanced treatments.

Addressing these challenges requires a multi-pronged approach, including optimizing the cost-effectiveness of flow diversion devices, improving reimbursement strategies, and expanding access to specialized care. Overcoming these barriers is essential to ensuring equitable patient access to life-saving treatments and ensuring the sustainability of healthcare systems.

Key Market Trends

A growing adoption of flow diversion techniques is a prominent trend in the market, with an increasing preference for flow diversion procedures as the primary method for managing cerebral aneurysms. Key factors contributing to this trend include:

Flow diversion procedures are less invasive compared to traditional open surgeries, attracting patients seeking treatments that offer quicker recovery times, reduced pain, and smaller incisions.

Flow diversion techniques have proven to be highly effective in treating complex aneurysms, such as wide-necked and fusiform aneurysms, that were previously difficult to manage. This effectiveness has led to greater trust and acceptance among both physicians and patients.

Ongoing innovations in flow diversion devices, including improvements in design, materials, and delivery systems, have enhanced their safety and efficacy, further promoting adoption.

Patients undergoing flow diversion procedures often experience positive outcomes, including lower rates of aneurysm recurrence and fewer complications, contributing to higher patient satisfaction and confidence in the treatment.

An increasing number of neurointerventionalists are being trained in flow diversion techniques, expanding the availability of these procedures in medical centers globally. The growing body of clinical evidence supporting the effectiveness of flow diversion in preventing aneurysm rupture is further driving its adoption.

Key Market Players

• Acandis GmbH
• BALT Group
• Cardinal Health Inc
• Endologix LLC
• Evasc Medical Systems Corp
• Imperative Care Inc
• InspireMD Inc
• Johnson & Johnson
• Lepu Medical Technology Beijing Co. Ltd
• Medtronic Plc

Market Segmentation

This report segments the global Flow Diversion Aneurysm Treatment Market into the following categories:

By Product:

• Flow Diverter Stents (FDS)
• Intrasaccular Flow Disruption Devices

By End User:

• Hospitals
• Specialty Clinics

By Region:

• North America (United States, Canada, Mexico)
• Europe (France, United Kingdom, Italy, Germany, Spain)
• Asia-Pacific (China, India, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

The report provides a detailed analysis of the major players in the Flow Diversion Aneurysm Treatment Market, including their strategies, market share, and key business developments.

Available Customizations

TechSci Research offers customizations for this global Flow Diversion Aneurysm Treatment Market report according to specific company needs. Customization options include:

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flow Diversion Aneurysm Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (FDS, Intrasaccular flow disruption devices)
  • 5.2.2. By End User (Hospitals, Specialty clinics)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Flow Diversion Aneurysm Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Flow Diversion Aneurysm Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End user
  • 6.3.2. Canada Flow Diversion Aneurysm Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End user
  • 6.3.3. Mexico Flow Diversion Aneurysm Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End user

7. Europe Flow Diversion Aneurysm Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End user
  • 7.3.2. United Kingdom Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End user
  • 7.3.3. Italy Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End user
  • 7.3.4. France Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End user
  • 7.3.5. Spain Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End user

8. Asia-Pacific Flow Diversion Aneurysm Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End user
  • 8.3.2. India Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End user
  • 8.3.3. Japan Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End user
  • 8.3.4. South Korea Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End user
  • 8.3.5. Australia Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End user

9. South America Flow Diversion Aneurysm Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Flow Diversion Aneurysm Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End user
  • 9.3.2. Argentina Flow Diversion Aneurysm Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End user
  • 9.3.3. Colombia Flow Diversion Aneurysm Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End user

10. Middle East and Africa Flow Diversion Aneurysm Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Flow Diversion Aneurysm Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End user
  • 10.3.2. Saudi Arabia Flow Diversion Aneurysm Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End user
  • 10.3.3. UAE Flow Diversion Aneurysm Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisition

13. Global Flow Diversion Aneurysm Treatment Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Acandis GmbH
  • 14.1.1. Business Overview
  • 14.1.2. Treatment Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
• 14.2. BALT Group
• 14.3. Cardinal Health Inc
• 14.4. Endologix LLC
• 14.5. Evasc Medical Systems Corp
• 14.6. Imperative Care Inc
• 14.7. InspireMD Inc
• 14.8. Johnson and Johnson
• 14.9. Lepu Medical Technology Beijing Co. Ltd
• 14.10.Medtronic Plc

15. Strategic Recommendations

16. About Us & Disclaimer